Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-727-3 | CAS number: 68909-99-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No acute toxicity studies of registered substance were available. The registered substance is a complex reaction mixture, containing N,N'-bis(3-aminopropyl)ethylenediamine (CAS No. 10563-26-5) and N-(2-aminoethyl)-1,3-propanediamine (CAS No. 13531-52-7) among others as majors components. These two components were used as surrogate to evaluate the toxicity of the registered substance. For further justification please refer to IUCLID chapter 13.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable study report wich meets basic scientific principles, however with the following restriction: Minimal details on test animals were given. For read across justification please refer to IUCLID chapter 13.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- BASF Test:
Several groups of 5 rats were treated by gavage with suspensions of the test substance in 0.5% Carboxylmethyl cellulose (CMC) aqueous preparation. Group-wise documentation of clinical signs was performed over the 14-day study period. Body weight was determined before the start of the study only, as it was needed for determination of dose. The clinical signs and findings were reported in summary form. - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: males 202 g, females 170 g (mean)
- Diet: Altromin R 124 (Altromin GmbH, Lage) - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Doses:
- 647, 950, 1397, 2043, 3002 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 1 140 mg/kg bw
- Mortality:
- LD50 = approx. 1200 µl/kg bw, corresponding to approx. 1140 mg/kg bw (relative density = 0.95)
- Clinical signs:
- other: Dyspnoea, poor general state, apathy, abdominal or lateral position, spastic gait, atonia, and diarrhoea were noted in the 1397, 2043 and 3002 mg/kg bw dose groups.
- Gross pathology:
- Necropsy findings of the animals that died comprised erythema of the intestinal mucosa, acute congestive hyperemia and dilatation of the heart, acute cachexia.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Dose (mg/kg bw)
|
Mortality Dead/Treated |
|||||||||
1 hour |
24 hours |
48 hours |
7 days |
14 days |
||||||
male |
female |
male |
female |
male |
female |
male |
female |
male |
female |
|
647 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
950 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
0/5 |
1/5 |
0/5 |
1/5 |
0/5 |
1397 |
0/5 |
0/5 |
1/5 |
2/5 |
3/5 |
2/5 |
5/5 |
4/5 |
5/5 |
4/5 |
2043 |
0/5 |
0/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
3002 |
1/5 |
0/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
5/5 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 140 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment. For read across justification please refer to IUCLID chapter 13.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- only one dose level
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- Vienna White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male: 3,29 kg (mean); female: 3,44 kg (mean)
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 50 cm²
REMOVAL OF TEST SUBSTANCE
- Washing (if done):
TEST MATERIAL
- Concentration (if solution): 100 %
- Duration of exposure:
- once
- Doses:
- 200 µl/kg
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes - Statistics:
- None
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 184 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Calculated from 0.2 ml/kg assuming test substance density of 0.92 g/ml
- Mortality:
- 2 male animals and 1 female animal died after 7 days.
- Clinical signs:
- other: slight apathy in all animals, apathy in 3 animals, urine tinged with blood in 3 of the 3 animals that died
- Gross pathology:
- - Animals that died spontaneously: Kidney (renal pelvis and urinary bladder filled with blood); Liver (focal mass necroses); lung (severe edema); heart (dilatation bilaterally)
- Animals sacrificed after 14 days: no adverse effects observed - Other findings:
- Necrosis was observed in all animals
Reference
Mortality
Dose (µl/kg) | Conc. (%) | No. of Animals | died within1 h | 24 h | 48 h | 7 d | 14 d |
200 | 100 | 3 male | 0/3 | 0/3 | 0/3 | 2/3 | 2/3 |
200 | 100 | 3 female | 0/3 | 0/3 | 0/3 | 1/3 | 1/3 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 184 mg/kg bw
Additional information
Oral:
Two acute oral studies are available on the single components of N3/N4-crude mix, one conducted with with N,N'-bis(3-aminopropyl)ethylenediamine (BASFAG.XXVI/100; CAS No. 10563-26-5) and one conducted with N-(2-aminoethyl)-1,3-propanediamine (BASFAG.XXVI/99; CAS No. 13531-52-7).
In the BASFAG.XXVI/100 study (reliability score: 2), largely conducted equivalent to methods described in OECD guideline 401, the LD50 for oral acute toxicity in rats was calculated as ca. 1140 mg/kg bw. Doses of 647, 950, 2040 and 3002 mg/kg bw of an aqueous solution in carboxymethyl cellulose were applied by gavage followed by a post dose observation period of 8 days. Main clinical signs observed were dyspnoea, poor general state, apathy, abdominal or lateral position, spastic gait, atonia, and diarrhoea, generally noted in the 1397, 2043 and 3002 mg/kg bw dose groups.. At necropsy, findings of the animals that died comprised erythema of the intestinal mucosa, acute congestive hyperemia and dilatation of the heart acute cachexia.
In the BASFAG.XXVI/99 study (reliability score: 2), also largely conducted equivalent to methods described in OECD guideline 401, the LD50 for oral acute toxicity in rats was calculated as ca. 654 mg/kg bw. Doses of 464, 1470, 681, 100, 14700 and 4640 mg/kg bw of an aqueous solution in aqua. dest (4.64 to 46.4%) were applied by gavage followed by a post dose observation period of 14 days. Main clinical signs observed were dyspnea, apathy, abdominal position, lateral position, stagger, atonia, tremor, reduced general condition, diarrhoe, spasctic gait as well as initial body weight loss partially or in some animals of all but the low dose group. At necropsy, findings of the animals that died comprised heart dilation, congestive hyperemia in the heart, atonic and dilated stomach, diffuse erythema in the gastro-oesophageal vestibule, as well as dilated gut with bloody diarrhea, observed partially or in all animals of all but the low dose group.
Dermal:
In the BASFAG.XXVI/100 study (reliability score: 2), largely conducted equivalent to methods described in OECD guideline 402, the LD50 for dermal acute toxicity in rats was calculated as ca. 190 mg/kg bw. 3 male and 3 female rabbits were shaven on their dorsal side and then treated for 24 h under occlusive conditions using one dose (200 µl/kg
bw, corresponding to 190 mg/kg bw)) of test substance. Animals were observed for 14 days, and those that died during the course of the study were submitted to necropsy. Survived animals at the end of the study were also subjected to gross-pathological examination. 1 rabbit died after 48 hours and 7 days respectively, and 2 rabbits died 14 days after treatment. Main clinical signs observed were Apathy, dispnoea, cyanosis, tremor, piloerection, blood-coloured urine with hematoma and poor general state. At necropsy, the animals that died during the observation period showed nephrosis, acute dilatation and acute hyperemia of the heart, edema appeared in the lung and the kidney were degenerated, whereas no abnormalities were observed on sacrificed animals.
The second BASF study BASFAG.XXVI/99 study (reliability score: 2), also largely conducted similar to the first one, and the LD50 for dermal acute toxicity in rats was calculated as ca. 184 mg/kg bw. 2 male animals and 1 female animal died after 7 days. Main clinical signs observed were slight apathy in all animals, apathy in 3 animals, urine tinged with blood in 3 of the 3 animals that died. At necropsy, findings of animals that died spontaneously were: kidney (renal pelvis and urinary bladder filled with blood); liver (focal mass necroses); lung (severe edema); heart (dilatation bilaterally). For the animals sacrificed after 14 days no adverse effects were observed.
Inhalation:
No study is available for the derivation of an acute LC50, neither for the test substance, nor for its surrogates. In an Inhalation Risk Test conducted with N-(2-aminoethyl)-1,3-propanediamine (CAS No. 13531-52-7), no mortality was observed when 12 rats were exposed for 8 hours to an atmosphere that has been saturated at 20 degrees centigrade with the volatile part of the compound. Signs of toxicity were attempt to escape, closure eyelid and eye irritation.
However, the mixture will be classified and labeled as harmful after acute inhalation due to the presence of ethanediamine (CAS No. 107-15-3) as a secondary constituent.
Justification for selection of acute toxicity – inhalation endpoint
There are no data available for N3/N4-amine. However, the mixture will be classified and labeled as harmful after acute inhalation due to the presence of ethanediamine (CAS No. 107-15-3) as a secondary constituent.
Justification for classification or non-classification
Based on the above described studies and considering the worst case assumption that the test substance contains 100% of its most toxic surrogate the test substance should be classified according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 as follows:
harmful if swallowed (GHS cat. 4) and fatal in contact with skin (GHS cat. 2)
Moreover, the mixture will be classified and labeled as harmful after acute inhalation (GHS cat. 4) due to the presence of ethanediamine (CAS No. 107-15-3) as a secondary constituent.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.